Across TCGA patient cohorts, KRTAP13-2 mutation is significantly associated with the RNA expression of many other genes, with 678 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible KRTAP13-2-associated genes across cancer lineages are TRAJ28, SPTLC1P5, and DDX23. Each is linked with KRTAP13-2 in more than 1 cancer types. Because this analysis shows association rather than direction, both KRTAP13-2-to-partner and partner-to-KRTAP13-2 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (KRTAP13-2→partner) and Y-score (partner→KRTAP13-2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
LIHC	TRAJ28 →	+0.492	+5.878	<.001	.002	3	2
LIHC	SPTLC1P5 →	+0.151	+5.186	<.001	.007	3	2
UCEC	DDX23 →	+0.450	+3.475	.006	.002	3	2
LUAD	RPLP0P1 →	+0.215	+3.786	.008	.005	3	2
UCEC	AEN →	+0.607	+3.475	.001	.002	3	2
LUSC	MIR3151 →	+0.686	+3.067	<.001	.005	3	2

Each partner links to its Q-omics profile. Showing the 6 strongest of 678 associations by consensus.

Exploration

KRTAP13-2 survival (RNA) · tumor vs normal (RNA) · all KRTAP13-2 data types